Diana Degan

Diana Degan

Auto-generated profile, based on publicly available information

Diana Degan

Department of Neurology, University of L'Aquila, L'Aquila, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2012 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
SSSimona Sacco
Simona Sacco
SRSilvia Ricci
Silvia Ricci
DDDiana Degan
Diana Degan
ACAntonio Carolei
Antonio Carolei
Migraine is a predominantly female disorder. Menarche, menstruation, pregnancy, and menopause, and also the use of hormonal contraceptives and hormone replacement treatment may influence migraine occurrence. Migraine usually starts after menarche, occurs more frequently in the days just before or during menstruation, and ameliorates during pregnancy and menopause. Those variations are mediated by fluctuation of estrogen levels through their influence on cellular excitability or cerebral vasculature. Moreover, administration of exogenous hormones may cause worsening of migraine as may expose migrainous women to an increased risk of vascular disease. In fact, migraine with aura represents a risk factor for stroke, cardiac disease, and vascular mortality. Studies have shown that administration of combined oral contraceptives to migraineurs may further increase the risk for ischemic stroke. Consequently, in women suffering from migraine with aura caution should be deserved when prescribing combined oral contraceptives.

1 May 2016 in Cardiology Clinics
Verified
Journal Article
Closed access
Francesca PistoiaFrancesca Pistoia
Francesca Pistoia
SSSimona Sacco
Simona Sacco
CTCindy Tiseo
Cindy Tiseo
DDDiana Degan
Diana Degan
RORaffaele Ornello
Raffaele Ornello
ACAntonio Carolei
Antonio Carolei

25 March 2015 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SSSimona Sacco
Simona Sacco
RORaffaele Ornello
Raffaele Ornello
PRP. Ripa
P. Ripa
CTC. Tiseo
C. Tiseo
DDD. Degan
D. Degan
ACA. Carolei
A. Carolei

28 March 2015 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
RORaffaele Ornello
Raffaele Ornello
PRPatrizia Ripa
Patrizia Ripa
Francesca PistoiaFrancesca Pistoia
Francesca Pistoia
DDDiana Degan
Diana Degan
CTCindy Tiseo
Cindy Tiseo
SSSimona Sacco
Simona Sacco
Background: Several studies have assessed the associations between migraine and underweight, pre-obesity or obesity, with conflicting results. To assess the consistency of the data on the topic, we performed a systematic review and meta-analysis of the available observational studies. Methods: Multiple electronic databases were systematically searched up to October 2014 for studies assessing the association between migraine and body mass index categories (underweight, pre-obesity, or obesity). Results: Out of 2,022 records, we included 15 studies. When considering the 11 studies following the World Health Organization BMI cutoffs, we found an increased risk of having migraine in underweight subjects (pooled adjusted effect estimate [PAEE] 1.21; 95% CI, 1.07-1.37; P = 0.002) and in obese women (PAEE 1.44; 95% CI, 1.05-1.97; P = 0.023) as compared with normal weight subjects; additionally, pre-obese subjects had an increased risk of having chronic migraine (PAEE 1.39; 95% CI, 1.13-1.71; P = 0.002). When considering all the 15 studies, we additionally found an increased risk of having migraine in obese as compared with normal weight subjects (PAEE 1.14; 95% CI, 1.02-1.27; P = 0.017); additionally, obese subjects had an increased risk of having chronic migraine (PAEE 1.75; 95% CI, 1.33-2.29; P < 0.001). The pooled analysis did not indicate an increased risk of having migraine in pre-obese subjects. Conclusions: The meta-analysis of the available observational studies suggested an association between migraine and obesity likely mediated by gender and migraine frequency. Further studies taking into account gender, migraine type, frequency, activity, and duration could provide more robust evidence.

10 July 2015 in High Blood Pressure & Cardiovascular Prevention
Verified
Journal Article
Closed access
PDF file
Francesca PistoiaFrancesca Pistoia
Francesca Pistoia
SSSimona Sacco
Simona Sacco
DDDiana Degan
Diana Degan
CTCindy Tiseo
Cindy Tiseo
RORaffaele Ornello
Raffaele Ornello
ACAntonio Carolei
Antonio Carolei

11 December 2014 in Cephalalgia
Verified
Journal Article
Closed access
SSSimona Sacco
Simona Sacco
Francesca PistoiaFrancesca Pistoia
Francesca Pistoia
DDDiana Degan
Diana Degan
ACAntonio Carolei
Antonio Carolei
Introduction: Migraine, in particular migraine with aura, has been found to be associated with cardiovascular disease. However, the role of conventional vascular risk factors in the association is still debated. The aim of the present review is to address the association between migraine and conventional cardiovascular risk factors as well as to address their possible role in the association between migraine and cardiovascular disease. Methods: Data for this review were obtained through searches in multiple sources up to May 2014 using the terms “migraine” OR “headache” in combination with all the vascular risk factors of interest. Results: Data about the possible association between migraine and high blood pressure values are heterogeneous, hindering any final conclusion. Data addressing the possible association between migraine and diabetes mellitus indicate the lack of any association or in some cases a negative association between the two conditions. The body of evidence on the role of dyslipidemia in migraineurs is relatively homogeneous and, with few exceptions, reports an association between migraine and an unfavorable lipid profile; however, the difference in lipid levels between migraineurs and non-migraineurs is small and its clinical implication unclear. Regarding obesity, a trend has been observed of increased risk of migraine with increasing obesity, especially in young patients, albeit in the midst of conflicting data. Evidence about the association between cigarette smoking and migraine mostly indicates that migraineurs are more commonly smokers than non-migraineurs. On the other hand, the majority of the available studies report less alcohol use in migraineurs than in non-migraineurs. Finally, many of the available studies suggest a more frequent family history of cardiovascular disease in migraineurs as compared to non-migraineurs. Since most of the studies that supported the association between migraine and cardiovascular disease adjusted the analyses for the presence of several vascular risk factors, they cannot entirely explain this association. Conclusions: Based on the available reported data, it seems unlikely that the higher risk of cardiovascular disease in migraineurs is mediated by any single vascular risk factor. For this reason the role of specific interactions among risk factors with the contribution of genetic, environmental, personality and psychological factors should be appropriately investigated.